Stock A200670 HUMEDIX CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Humedix Co., Ltd.

Equities

A200670

KR7200670008

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 05/06/2024 am IST 		5-day change 1st Jan Change
34,450 KRW -1.57% Intraday chart for Humedix Co., Ltd. +2.84% +2.07%
24/05 Humedix Co., Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares. CI
24/05 Humedix Co., Ltd. authorizes a Buyback Plan. CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Humedix Co., Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares.
CI
Humedix Co., Ltd. authorizes a Buyback Plan.
CI
Tranche Update on Humedix Co., Ltd.'s Equity Buyback Plan announced on September 27, 2022.
CI
Humedix Co., Ltd.'s Equity Buyback announced on September 27, 2022, has expired with 145,877 shares, representing 1.58% for KRW 2,992.33 million.
CI
Ensol Biosciences Inc. announced that it has received KRW 4.99999995 billion in funding from Humedix Co., Ltd.
CI
Ensol Biosciences Inc. announced that it expects to receive KRW 4.99999995 billion in funding from Humedix Co., Ltd.
CI
Tranche Update on Humedix Co., Ltd.'s Equity Buyback Plan announced on September 27, 2022.
CI
Humedix Co., Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares.
CI
Humedix Co., Ltd. authorizes a Buyback Plan.
CI
Tranche Update on Humedix Co., Ltd.'s Equity Buyback Plan announced on March 16, 2022.
CI
Tranche Update on Humedix Co., Ltd.'s Equity Buyback Plan announced on March 16, 2022.
CI
Humedix Co., Ltd.'s Equity Buyback announced on March 16, 2022, has expired with 136,591 shares, representing 1.46% for KRW 2,982.87 million.
CI
An unknown buyer agreed to acquire a 22.3% stake in Huons Meditech from Humedix Co., Ltd. for KRW 21.5 billion.
CI
Tranche Update on Humedix Co., Ltd.'s Equity Buyback Plan announced on March 16, 2022.
CI
Humedix Co., Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares.
CI
Humedix Co., Ltd. authorizes a Buyback Plan.
CI
Kineta, Inc. announced that it has received funding from Humedix Co., Ltd.
CI
Kineta, Inc. announced that it expects to receive funding from Humedix Co., Ltd.
CI
Huons Global : S.Korean consortium to produce 100 mln doses a month of Russia's Sputnik V vaccine
RE
Humedix Co., Ltd. announced that it has received KRW 45 billion in funding from a group of investors
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A200670 Stock
  4. News Humedix Co., Ltd.